Serum Institute of India | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
June 15, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JUNE 15, 2025

Serum Institute of India

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui
Coronavirus chronicle

Serum India’s Covishield part of Pakistan’s Covid-jab drive under vaccine alliance

The UN Covax initiative will see India selling about 100 lakh doses of vaccines. In addition, the UN will be buying about 4 lakh doses for its own workers all over the world

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui
Coronavirus chronicle

Mexico to import AstraZeneca vaccine from India, president says

A medical worker receives the AstraZeneca's Covishield coronavirus disease (Covid-19) vaccine in Yangon, Myanmar, after the country received 1.5 million doses of the vaccine manufactured by the Serum Institute of India, January 27, 2021. REUTERS/Shwe Paw Mya Tin
Coronavirus chronicle

Myanmar launches vaccination drive, prioritises frontline healthcare workers

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Saudi Arabia to get AstraZeneca shots in about a week from India

Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (Covid-19) pandemic, in Koraput, India, January 16, 2021. REUTERS/Danish Siddiqui
Coronavirus chronicle

From factory to faraway village: Behind India's mammoth vaccination drive

Photo/Courtesy
Covid-19 in Bangladesh

50 lakh doses of Oxford vaccine reach Dhaka 

50 lakh doses of Oxford vaccines due today
Covid-19 in Bangladesh

50 lakh doses of Oxford vaccines due today

File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Covax announces new agreement, plans for first deliveries

Vaccines are safe, Serum CEO says after fire at its plant
World+Biz

Vaccines are safe, Serum CEO says after fire at its plant

Representational image. Picture: Collected
Coronavirus chronicle

Covid-19 vaccines: Fact sheets in India warn against use in immuno-compromised

A woman walks past a painting of Indian Prime Minister Narendra Modi a day before the inauguration of the Covid-19 vaccination drive on a street in Mumbai, India, January 15, 2021. REUTERS/Francis Mascarenhas
Coronavirus chronicle

India kicks off 'world's largest' vaccination campaign

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas
Coronavirus chronicle

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses

Oxford-AstraZeneca's Covid-19 vaccine. Photo: Reuters.
Covid-19 in Bangladesh

India's Serum to sell AstraZeneca vaccine to Bangladesh at $4/dose

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net